Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
Koay EJ, Teh BS, Paulino AC, Butler EB.
Cancer. 2011 Dec 1;117(23):5325-33. doi: 10.1002/cncr.26197. Epub 2011 May 12.
Related citations
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
Abogunrin F, O'Kane HF, Ruddock MW, Stevenson M, Reid CN, O'Sullivan JM, Anderson NH, O'Rourke D, Duggan B, Lamont JV, Boyd RE, Hamilton P, Nambirajan T, Williamson KE.
Cancer. 2012 May 15;118(10):2641-50. doi: 10.1002/cncr.26544. Epub 2011 Sep 14.
Lotan Y.
Cancer. 2012 May 15;118(10):2566-7. doi: 10.1002/cncr.26535. Epub 2011 Sep 14. No abstract available.
Quality of care in patients with bladder cancer: a case report?
Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS; Urologic Diseases in America Project.
Cancer. 2012 Mar 1;118(5):1412-21. doi: 10.1002/cncr.26402. Epub 2011 Aug 5.
Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
Inoue K, Fukuhara H, Shimamoto T, Kamada M, Iiyama T, Miyamura M, Kurabayashi A, Furihata M, Tanimura M, Watanabe H, Shuin T.
Cancer. 2012 Feb 15;118(4):1062-74. doi: 10.1002/cncr.26378. Epub 2011 Jul 19.
Compliance with guidelines for patients with bladder cancer: variation in the delivery of care.
Cancer. 2011 Dec 1;117(23):5392-401. doi: 10.1002/cncr.26198. Epub 2011 Jul 11.
Preoperative chemotherapy for bladder cancer: a standard waits to be optimally deployed.
Sonpavde G, Shariat SF.
Cancer. 2012 Jan 1;118(1):8-11. doi: 10.1002/cncr.26239. Epub 2011 Jul 5. No abstract available.
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.
Shariat SF, Savage C, Chromecki TF, Sun M, Scherr DS, Lee RK, Lughezzani G, Remzi M, Marberger MJ, Karakiewicz PI, Vickers AJ.
Cancer. 2011 Jul 1;117(13):2892-7. doi: 10.1002/cncr.25903. Epub 2011 Jan 10.
A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer.
Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM.
Cancer. 2012 Jan 15;118(2):358-64. doi: 10.1002/cncr.26278. Epub 2011 Jun 29.
Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
Xing J, Dinney CP, Shete S, Huang M, Hildebrandt MA, Chen Z, Gu J.
Cancer. 2012 Jan 1;118(1):205-15. doi: 10.1002/cncr.26224. Epub 2011 Jun 20.
Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach.
Alva AS, Tallman CT, He C, Hussain MH, Hafez K, Montie JE, Smith DC, Weizer AZ, Wood D, Lee CT.
Cancer. 2012 Jan 1;118(1):44-53. doi: 10.1002/cncr.26240. Epub 2011 May 19.
Etiologic role of human papillomavirus infection in bladder carcinoma.
Shigehara K, Sasagawa T, Kawaguchi S, Nakashima T, Shimamura M, Maeda Y, Konaka H, Mizokami A, Koh E, Namiki M.
Cancer. 2011 May 15;117(10):2067-76. doi: 10.1002/cncr.25777. Epub 2010 Nov 29.
Expression and function role of DNA methyltransferase 1 in human bladder cancer.
Wu CT, Wu CF, Lu CH, Lin CC, Chen WC, Lin PY, Chen MF.
Cancer. 2011 Nov 15;117(22):5221-33. doi: 10.1002/cncr.26150. Epub 2011 Apr 26.
Diabetes and risk of bladder cancer: evidence from a case-control study in New England.
MacKenzie T, Zens MS, Ferrara A, Schned A, Karagas MR.
Cancer. 2011 Apr 1;117(7):1552-6. doi: 10.1002/cncr.25641. Epub 2010 Nov 8.
Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.
Stenzl A, Penkoff H, Dajc-Sommerer E, Zumbraegel A, Hoeltl L, Scholz M, Riedl C, Bugelnig J, Hobisch A, Burger M, Mikuz G, Pichlmeier U.
Cancer. 2011 Mar 1;117(5):938-47. doi: 10.1002/cncr.25523. Epub 2010 Nov 8.
Error occurred: cannot get document summary
Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.
Schultz L, Albadine R, Hicks J, Jadallah S, DeMarzo AM, Chen YB, Nielsen ME, Gonzalgo ML, Sidransky D, Schoenberg M, Netto GJ.
Cancer. 2010 Dec 1;116(23):5517-26. doi: 10.1002/cncr.25502. Epub 2010 Oct 11. Erratum in: Cancer. 2011 Nov 1;117(21):5021. Neilsen, Matthew E [corrected to Nielsen, Matthew E].
Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis.
Kramer MW, Escudero DO, Lokeshwar SD, Golshani R, Ekwenna OO, Acosta K, Merseburger AS, Soloway M, Lokeshwar VB.
Cancer. 2011 Mar 15;117(6):1197-209. doi: 10.1002/cncr.25565. Epub 2010 Oct 19.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on